# KONEXT Secures 15 Billion KRW, Pharmarise Becomes Shareholder

- Link: https://www.venturesquare.net/1053968/
- Discussion: https://startupxo.com/en/110/
- Posted by mrlatte at 2026-03-16T06:57:14.000Z
- 1 point, 0 comments, kind story, origin archive
- Written in ko, machine translated to en

## Summary

- Pharmarise joined KONEXT's 15 billion KRW Series C investment as a strategic investor.
- For bio founders, the point of interest is securing a partner who can support from clinical trials to commercialization, along with the investment amount.
- However, merely participating in the investment does not necessarily accelerate the development schedule; clear agreements on who takes on what tasks and by when are necessary to expect support beyond funding in actual collaboration.

## Comments (0)

No comments yet.

JSON: https://startupxo.com/api/v1/item.json?id=110&lang=en
